On March 31, 2024, the 144th Annual Meeting of the Pharmaceutical Society of Japan/Sera Bio-Pharma Co. held a luncheon seminar (seminar title: Highly Absorbed Curcumin for Healthy Longevity - Scientific Evidence of curcuRouge®).
In this luncheon seminar, the efficacy of curcuRouge® in (1) novel coronary infection and improvement of immune function, (2) improvement of cardiac function in animal models of myocardial infarction, and (3) effect on knee osteoarthritis were introduced by three authorities under the chairmanship of Dr. Kakeya, Professor, Graduate School of Pharmaceutical Sciences, Kyoto University. Afterwards, the role of curcuRouge® in a healthy and long-lived society was discussed. (Please see the video and the brochure for more details on the topics.)
Effectiveness of curcuRouge® against COVID-19 infections and a lowering effect on the neutrophil-lymphocyte ratio
Koji Hasegawa (Director, Division of Translational Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center)
The effects of curcuRouge® in a rat model of Myocardial Infarction
Tatsuya Morimoto (Professor, Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka)
The effect of curcuRouge® on osteoarthritis of the knee
Yasuaki Nakagawa (Chief of Orthopaedic Surgery Department, Japan Baptist Hospital)
